77 related articles for article (PubMed ID: 3003957)
1. The prevalence of HTLV-III and HTLV-I antibodies in serum of hemophiliacs.
De Rossi A; Dalla Gassa O; Chieco Bianchi L; Dal Bo Zanon R; Boscaro M; Girolami A
Thromb Haemost; 1985 Dec; 54(4):897. PubMed ID: 3003957
[No Abstract] [Full Text] [Related]
2. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
Muncunill J; Forteza A; Forner N; Forteza-Rei J
Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
[No Abstract] [Full Text] [Related]
3. Association of HTLV-III antibodies and cellular immune status of hemophiliacs.
Tsoukas C; Gervais F; Shuster J; Gold P; O'Shaughnessy M; Robert-Guroff M
N Engl J Med; 1984 Dec; 311(23):1514-5. PubMed ID: 6095077
[No Abstract] [Full Text] [Related]
4. [Preventive measures against HTLV-III/LAV infections among hemophiliacs and their relatives].
Evensen SA; Frøland SS; Glomstein A
Tidsskr Nor Laegeforen; 1986 Jan; 106(1):19-21. PubMed ID: 3006278
[No Abstract] [Full Text] [Related]
5. Detection of antibodies to human T-lymphotropic viruses type I and III in Japanese hemophiliacs.
Koyanagi Y; Kobayashi S; Harada S; Kikukawa R; Yamamoto N; Watanabe K; Okino F; Kajii T
AIDS Res; 1983-1984; 1(5):353-8. PubMed ID: 6100780
[TBL] [Abstract][Full Text] [Related]
6. [The occurrence of LAV/HTLV III antibodies in patients with hemophilia in the County of Funen].
Larsen FS; Høst A; Munk-Andersen G
Ugeskr Laeger; 1986 Mar; 148(14):865-7. PubMed ID: 3010526
[No Abstract] [Full Text] [Related]
7. HTLV-III status and abnormalities in T lymphocyte distribution in children with hemophilia A.
Shannon BT; Roach J; Cheek-Luten M; Ruymann FB
Diagn Immunol; 1986; 4(1):37-42. PubMed ID: 3006971
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to human T-cell leukemia virus type III in hemophiliacs from Spain.
Kitchen L; Leal M; Wichmann I; Lissen E; Ollero M; Allan JS; McLane MF; Essex M
Blood; 1985 Dec; 66(6):1473-5. PubMed ID: 2998515
[TBL] [Abstract][Full Text] [Related]
9. HTLV and immunosuppression.
Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
[TBL] [Abstract][Full Text] [Related]
10. Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report.
Lynn TC; Hsieh RP; Lin KT; Shen MC; Chen DS; Wang CH; Liu CH; Wang JH; Lai MY; Liou MF
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Aug; 17(3):172-6. PubMed ID: 6096089
[TBL] [Abstract][Full Text] [Related]
11. HTLV-III antibody status in household contacts of seropositive hemophiliacs.
Muntean W; Zenz W; Zaunschirm W; Teubl I; Heinz FX
Blood; 1986 Jun; 67(6):1780-1. PubMed ID: 3011153
[No Abstract] [Full Text] [Related]
12. [Anti-HTLV-III in hemophilic patients in Barcelona].
Hernández Sánchez JM; Piqueras J; Vila M; Tusell J; Triginer J
Sangre (Barc); 1985; 30(5):857-63. PubMed ID: 3003939
[No Abstract] [Full Text] [Related]
13. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
Verani P; Mariani G; Mannucci PM; De Rossi G; Nicoletti L; Titti F; Falcione E; Pasqualetti D; Ammassari M; Gringeri A
J Med Virol; 1986 Jun; 19(2):143-9. PubMed ID: 3014059
[TBL] [Abstract][Full Text] [Related]
14. Increase in prevalence of anti-HTLV-III in haemophiliacs.
Gürtler LG; Wernicke D; Eberle J; Zoulek G; Deinhardt F; Schramm W
Lancet; 1984 Dec; 2(8414):1275-6. PubMed ID: 6150304
[No Abstract] [Full Text] [Related]
15. HTLV-III/LAV-seronegative, virus-negative sexual partners and household contacts of hemophiliacs.
McFadden T; Jason JM; Feorino P
JAMA; 1986 Apr; 255(13):1702. PubMed ID: 3005673
[No Abstract] [Full Text] [Related]
16. Predictive value of a screening test for antibodies to HTLV-III.
Sivak SL; Wormser GP
Am J Clin Pathol; 1986 Jun; 85(6):700-3. PubMed ID: 3010700
[TBL] [Abstract][Full Text] [Related]
17. Human T cell leukemia virus type I and Epstein-Barr virus antibodies in homosexuals and hemophilia patients from Venezuela.
Merino F; DeSalvo L; Medina JW
AIDS Res; 1984-1985; 1(6):395-400. PubMed ID: 6100781
[TBL] [Abstract][Full Text] [Related]
18. [Anti-HTLV-I antibody and anti-HIV antibody in hemophiliacs, patients with renal disease and blood donors].
Kohno S; Masuyama Y; Dohtsu Y; Miyazaki T; Koga H; Yokoyama K; Taura K; Harada T; Yamaguchi K; Izumikawa K
Kansenshogaku Zasshi; 1987 May; 61(5):567-73. PubMed ID: 2822821
[No Abstract] [Full Text] [Related]
19. Prevalence of antibodies to human T-lymphotropic virus-III (HTLV-III) in hemophiliacs and other patients chronically substituted with blood products.
Erfle V; Hehlmann R; Mellert W; Goebel FD; Rasokat H; Lechler E; Hellstern P; Köhler M; Seifried E; Heimpel H
Blut; 1985 Oct; 51(4):243-9. PubMed ID: 2996664
[TBL] [Abstract][Full Text] [Related]
20. [Immunological status of hemophiliacs: study of blood T-lymphocyte populations, serum immunoglobulins, and the prevalence of anti-LAV antibodies].
Aymard JP; Janot C; Briquel ME; André E; Schooneman F; Vigneron C; Legras B; Alexandre P; Streiff F
Pathol Biol (Paris); 1985 Dec; 33(10):951-6. PubMed ID: 3005949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
